Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chie Nishioka
Observed names:
C Nishioka,
西岡,千絵
Institutions:
University of Kochi,
Kōchi University
Observed institutions:
University of Kochi,
Japan Society for the Promotion of Science,
Kochi Medical School Hospital,
Japan Society for the Promotion of Science London,
Kōchi University
OpenAlex ID:
A5011318878
Works
83
Awards
1
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
2007
·
Jing Yang
, Takayuki Ikezoe
, et al.
·
Blood
·
315
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
2007
·
Takayuki Ikezoe
, Jing Yang
, et al.
·
Molecular Cancer Therapeutics
·
141
PDF
Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells
2006
·
Takayuki Ikezoe
, Chie Nishioka
, et al.
·
Leukemia Research
·
130
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling
2006
·
Takayuki Ikezoe
, Chie Nishioka
, et al.
·
Molecular Cancer Therapeutics
·
110
PDF
MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells
2008
·
Chie Nishioka
, Takayuki Ikezoe
, et al.
·
Leukemia Research
·
92
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
2008
·
C Nishioka
, T Ikezoe
, et al.
·
Leukemia
·
89
PDF
A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies
2009
·
T Ikezoe
, J Yang
, et al.
·
Leukemia
·
77
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines
2006
·
Y Yang
, T Ikezoe
, et al.
·
British Journal of Cancer
·
72
PDF
Downregulation of miR‐217 correlates with resistance of ph+ leukemia cells to ABL tyrosine kinase inhibitors
2014
·
Chie Nishioka
, Takayuki Ikezoe
, et al.
·
Cancer Science
·
67
PDF
Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor κB
2007
·
Chie Nishioka
, Takayuki Ikezoe
, et al.
·
Leukemia Research
·
62
Thrombomodulin Protects Endothelial Cells From a Calcineurin Inhibitor–Induced Cytotoxicity by Upregulation of Extracellular Signal–Regulated Kinase/Myeloid Leukemia Cell-1 Signaling
2012
·
Takayuki Ikezoe
, Jing Yang
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
61
Effect of SU11248 on gastrointestinal stromal tumor‐T1 cells: Enhancement of growth inhibition via inhibition of 3‐kinase/Akt/mammalian target of rapamycin signaling
2006
·
Takayuki Ikezoe
, Yang Yang
, et al.
·
Cancer Science
·
57
PDF
Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
2011
·
Takayuki Ikezoe
, Shinsuke Kojima
, et al.
·
International Journal of Cancer
·
54
PDF
Long‐term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene
2011
·
Jing Yang
, Takayuki Ikezoe
, et al.
·
International Journal of Cancer
·
50
PDF
Serum level of soluble CD30 correlates with the aggressiveness of adult T‐cell leukemia/lymphoma
2005
·
Chie Nishioka
, Shigeki Takemoto
, et al.
·
Cancer Science
·
48
PDF
Inhibition of mammalian target of rapamycin signaling potentiates the effects of all‐trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells
2009
·
Chie Nishioka
, Takayuki Ikezoe
, et al.
·
International Journal of Cancer
·
47
Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene
2010
·
C Nishioka
, T Ikezoe
, et al.
·
Leukemia
·
44
CD34+/CD38− acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells
2012
·
Chie Nishioka
, Takayuki Ikezoe
, et al.
·
International Journal of Cancer
·
43
PDF
Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of AML cells in vitro and in vivo
2010
·
Jing Yang
, Takayuki Ikezoe
, et al.
·
Experimental Hematology
·
43
Blockade of MEK/ERK signaling enhances sunitinib-induced growth inhibition and apoptosis of leukemia cells possessing activating mutations of the FLT3 gene
2007
·
Chie Nishioka
, Takayuki Ikezoe
, et al.
·
Leukemia Research
·
43
Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling
2013
·
Jing Yang
, Takayuki Ikezoe
, et al.
·
International Journal of Cancer
·
42
PDF
Analysis of Aurora B kinase in non-Hodgkin lymphoma
2009
·
Takayuki Ikezoe
, Tamotsu Takeuchi
, et al.
·
Laboratory Investigation
·
42
PDF
CD34+/CD38−acute myelogenous leukemia cells aberrantly express Aurora kinase A
2013
·
Jing Yang
, Takayuki Ikezoe
, et al.
·
International Journal of Cancer
·
39
PDF
STAT5A regulates DNMT3A in CD34+/CD38− AML cells
2015
·
Asako Takeuchi
, Chie Nishioka
, et al.
·
Leukemia Research
·
37
p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells
2009
·
Takayuki Ikezoe
, Jing Yang
, et al.
·
International Journal of Hematology
·
37
Show more works
View as search
Works count:
83
Citation count:
2,703
H-index:
32
I10-index:
59
Year
Topic
Type